Organon & Co. SEC filings OGN
Organon & Co. has 461 filings in SEC EDGAR's recent list, going back to Nov 2, 2020. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Other events
|
Jul 17, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Apr 27, 2026 | Apr 26, 2026 |
| 8-K |
Current report
Other events
|
Feb 20, 2026 | Feb 20, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 7, 2025 | Nov 3, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 30, 2025 | Oct 26, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 27, 2025 | Oct 26, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Other events
|
May 27, 2025 | May 27, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
May 1, 2025 | May 1, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 15, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 13, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 21, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Other events
|
Dec 23, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 6, 2024 | Dec 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 23, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
May 17, 2024 | May 17, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 15, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 5, 2023 | Dec 1, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 16, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Dec 9, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 12, 2022 | Jul 7, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 6, 2022 | May 5, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 17, 2022 | Feb 17, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2021 | Nov 11, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2021 | Jun 29, 2021 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 3, 2021 | Jun 2, 2021 |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OGN (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Jersey City, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1821825
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.